These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1139 related items for PubMed ID: 15199494

  • 21. The risk of cardiovascular disease with second- and third-generation oral contraceptives.
    Kovacs P.
    Medscape Womens Health; 2002; 7(4):3. PubMed ID: 12466735
    [No Abstract] [Full Text] [Related]

  • 22. [Oral contraceptives increase deep venous thrombosis in smoking women].
    Tsankova V, Petrov V, Astrug A.
    Akush Ginekol (Sofiia); 2010; 49(5):8-13. PubMed ID: 21268396
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC.
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [Abstract] [Full Text] [Related]

  • 27. Oral contraceptive pills and the risk of venous thromboembolism.
    Prog Hum Reprod Res; 1996 Apr; (39):2-3. PubMed ID: 12292198
    [Abstract] [Full Text] [Related]

  • 28. Oral contraceptives and myocardial infarction: new evidence leaves unanswered questions.
    Thorogood M.
    Thromb Haemost; 1997 Jul; 78(1):334-8. PubMed ID: 9198175
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?
    Speroff L.
    Johns Hopkins Med J; 1982 May; 150(5):170-6. PubMed ID: 7043035
    [Abstract] [Full Text] [Related]

  • 34. [Significance of hormonal contraceptives for coronary heart disease].
    Gohlke-Bärwolf C.
    Herz; 1987 Aug; 12(4):263-75. PubMed ID: 3308662
    [Abstract] [Full Text] [Related]

  • 35. Thrombotic diseases in young women and the influence of oral contraceptives.
    Lidegaard O.
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S62-7. PubMed ID: 9753312
    [Abstract] [Full Text] [Related]

  • 36. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
    Gomes MP, Deitcher SR.
    Arch Intern Med; 2004 Oct 11; 164(18):1965-76. PubMed ID: 15477430
    [Abstract] [Full Text] [Related]

  • 37. [Third generation progestagens].
    Belaisch J, Eliakim V.
    Contracept Fertil Sex (Paris); 1993 Apr 11; 21(4):287-93. PubMed ID: 12318226
    [Abstract] [Full Text] [Related]

  • 38. Venous thromboembolism in relation to oral contraceptive use.
    Helmrich SP, Rosenberg L, Kaufman DW, Strom B, Shapiro S.
    Obstet Gynecol; 1987 Jan 11; 69(1):91-5. PubMed ID: 3796927
    [Abstract] [Full Text] [Related]

  • 39. Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use.
    Pomp ER, Rosendaal FR, Doggen CJ.
    Am J Hematol; 2008 Feb 11; 83(2):97-102. PubMed ID: 17726684
    [Abstract] [Full Text] [Related]

  • 40. Myocardial infarction and stroke in young women: what is the impact of oral contraceptives?
    Lewis MA.
    Am J Obstet Gynecol; 1998 Sep 11; 179(3 Pt 2):S68-77. PubMed ID: 9753313
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 57.